DOES ALPHA-1-ACID GLYCOPROTEIN REDUCE THE UNBOUND METABOLIC-CLEARANCE OF DISOPYRAMIDE IN PATIENTS WITH RENAL IMPAIRMENT

被引:7
作者
BRAUN, J
SORGEL, F
GLUTH, WP
OIE, S
机构
[1] INST BIOMED & PHARMACEUT RES,NURNBERG,FED REP GER
[2] UNIV ERLANGEN NURNBERG,INST FORENS MED,D-8520 ERLANGEN,FED REP GER
[3] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143
关键词
D O I
10.1007/BF00558271
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:313 / 317
页数:5
相关论文
共 32 条
[11]  
HUANG JD, 1984, J TAIWAN PHARM ASS, V36, P69
[12]   PHARMACOKINETICS OF ORAL DISOPYRAMIDE PHOSPHATE IN PATIENTS WITH RENAL IMPAIRMENT [J].
JOHNSTON, A ;
HENRY, JA ;
WARRINGTON, SJ ;
HAMER, NAJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) :245-248
[13]  
KABRA PM, 1981, THER DRUG MONIT, V3, P91
[14]  
KANFER A, 1987, CLIN NEPHROL, V55, P147
[15]   CLINICAL PHARMACOKINETICS OF DISOPYRAMIDE [J].
KARIM, A ;
NISSEN, C ;
AZARNOFF, DL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (05) :465-494
[16]   KINETICS, DYNAMICS, AND BIOAVAILABILITY OF BUMETANIDE IN HEALTHY-SUBJECTS AND PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
LAU, HSH ;
HYNECK, ML ;
BERARDI, RR ;
SWARTZ, RD ;
SMITH, DE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) :635-645
[17]   DISOPYRAMIDE PHARMACOKINETICS AND BIOAVAILABILITY FOLLOWING THE SIMULTANEOUS ADMINISTRATION OF DISOPYRAMIDE AND C-14-DISOPYRAMIDE [J].
LIMA, JJ ;
HAUGHEY, DB ;
LEIER, CV .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (03) :289-313
[18]  
LIMA JJ, 1981, J PHARMACOL EXP THER, V219, P741
[19]  
MACHIEWICZ A, 1987, ARTHRITIS RHEUM, V30, P513
[20]   ROLE OF CONCENTRATION-DEPENDENT PLASMA-PROTEIN BINDING IN DISOPYRAMIDE DISPOSITION [J].
MEFFIN, PJ ;
ROBERT, EW ;
WINKLE, RA ;
HARAPAT, S ;
PETERS, FA ;
HARRISON, DC .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01) :29-46